Literature DB >> 9125048

Characterization of neutralizing domains on varicella-zoster virus glycoprotein E defined by monoclonal antibodies.

L Wu1, B Forghani.   

Abstract

The genome of varicella-zoster virus (VZV), encodes at least six glycoproteins and they elicit the formation of complement-independent, complement-dependent, and non-neutralizing antibody responses. We have used our library of MAbs to VZV glycoprotein E (gE) to determine the neutralizing epitopes of gE, and shown that gE has 3 distinct neutralizing domains. In this report we have used the baculovirus expression system to identify the antigenic domains of gE. We have generated 3 recombinant baculoviruses, expressing the full-length gE and two overlapping truncated forms (the amino-terminal and the carboxy-terminal) of gE. By immuno-fluorescence and immunoblotting we have explored the physical interactions of Mabs to gE on these constructs. Our panel of MAbs revealed 3 district antigenic domains on gE. All MAbs reacted with the full-length gE; MAbs with high titered complement-dependent neutralizing activities reacted with the N-terminal truncated gE; MAbs with low titered or non-neutralizing activities reacted with the C-terminal truncated gE; MAbs with complement-enhanced neutralizing activities reacted with both truncated constructs. However, although the antibody binding in immunofluorescence and immunoblotting was carried out under denatured conditions, whereas the neutralization is under non-denatured conditions, still the antigenic mapping was similar in both conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125048     DOI: 10.1007/s007050050081

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  4 in total

1.  The amino terminus of varicella-zoster virus (VZV) glycoprotein E is required for binding to insulin-degrading enzyme, a VZV receptor.

Authors:  Qingxue Li; Tammy Krogmann; Mir A Ali; Wei-Jen Tang; Jeffrey I Cohen
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

2.  Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread.

Authors:  Qingxue Li; Mir A Ali; Jeffrey I Cohen
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

3.  Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.

Authors:  Nicole L Sullivan; Morgan A Reuter-Monslow; Janet Sei; Eberhard Durr; Carl W Davis; Cathy Chang; Megan McCausland; Andreas Wieland; David Krah; Nadine Rouphael; Aneesh K Mehta; Mark J Mulligan; Bali Pulendran; Rafi Ahmed; Kalpit A Vora
Journal:  J Virol       Date:  2018-06-29       Impact factor: 6.549

4.  Expression of variable viruses as herpes simplex glycoprotein D and varicella zoster gE glycoprotein using a novel plasmid based expression system in insect cell.

Authors:  A M Al-Sulaiman; P J Vallely; P E Klapper; Raid Al Baradie; Shaihana Abdulrahman Almatrrouk; Khalid K Alharbi
Journal:  Saudi J Biol Sci       Date:  2016-05-10       Impact factor: 4.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.